Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study

Objectives: Adjuvant immunotherapy is an innovative therapeutic option that might potentially improve outcome of early-stage non-small cell lung cancer. Melanoma associated antigen (MAGE)-A3 is a promising target for immunotherapy because it is exclusively presented on the cell surface of cancer cel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cardio-thoracic surgery 2004-01, Vol.25 (1), p.131-134
Hauptverfasser:	Sienel, W., Varwerk, C., Linder, A., Kaiser, D., Teschner, M., Delire, M., Stamatis, G., Passlick, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, Neoplasm - metabolism Biological and medical sciences Biomarkers, Tumor - metabolism Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Dermatology Humans Immunotherapy Lung Neoplasms - metabolism Lung Neoplasms - pathology Medical sciences Melanoma associated antigen-A3 expression Neoplasm Proteins Non-small-cell cancer Reverse Transcriptase Polymerase Chain Reaction - methods RNA, Neoplasm - metabolism Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!